Kilitch Drugs P/B Ratio

Current P/B Ratio
2.05
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Kilitch Drugs (KILITCH) P/B ratio is 2.05 (Moderate), book value per share ₹125.62 vs Healthcare average P/B of -0.94 — High - Premium to book value, growth expectations or asset-light model. View KILITCH 52-week high low for the annual high/low range and current price position.

Current Valuation Metrics

P/B Ratio 2.05
Current Price ₹183.06
Book Value/Share ₹125.62
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹201 Cr
Share Capital ₹16 Cr
Reserves & Surplus ₹186 Cr
Outstanding Shares 16,000,000
Book Value per Share ₹125.62

Valuation Signal

Signal Fairly Valued
Historical Avg 2.86
Historical Range 1.74 - 3.85
Percentile 20.0%

Sector Context

Sector Average -0.94
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

KILITCH P/B Ratio — Valuation Insights & Book Value Analysis

Kilitch Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 2.05 (Moderate). For live price, earnings yield and the full fundamental profile, see KILITCH share price.

  • Current PB is 28.3% below historical average
  • Trading at premium to sector average PB of -0.94

Kilitch Drugs P/B Ratio Historical Trend

KILITCH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with KILITCH fundamental valuation to assess whether the stock is under or overvalued.

KILITCH Historical P/B Ratio — Book Value Per Share & Year-End Price

Kilitch Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 2.79 ₹125.62 ₹350.20 ₹201 Moderate
2024 2.89 ₹110.0 ₹318.40 ₹176 Moderate
2023 3.85 ₹94.38 ₹363.80 ₹151 High
2022 1.74 ₹87.5 ₹152.65 ₹140 Moderate
2021 3.02 ₹81.25 ₹245.40 ₹130 High

KILITCH vs Healthcare Peers — P/B Ratio Comparison

Kilitch Drugs P/B 2.05 vs Healthcare average -0.94, median 0.6 — range -31.21–1.03.

Sector Average
-0.94
Sector Median
0.6
Lowest P/B
-31.21
Highest P/B
1.03
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -31.21 ₹25 Low
Sun Pharma Advanced Rese… SPARC -16.05 ₹5,310 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.31 ₹75 Low
Parmax Pharma PARMAX -2.16 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.76 ₹121 Low
Cresanto Global CRESANTO -0.7 ₹2 Low